Inhibition of TMPRSS2 and 3CL Proteases by natural polyphenols to prevent SARS-CoV-2 infectivity and replication
天然多酚抑制 TMPRSS2 和 3CL 蛋白酶以防止 SARS-CoV-2 感染和复制
基本信息
- 批准号:554328-2020
- 负责人:
- 金额:$ 3.64万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Alliance Grants
- 财政年份:2020
- 资助国家:加拿大
- 起止时间:2020-01-01 至 2021-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In this research, we propose to prove that polyphenols (PLs) can inhibit the harmful effects of the SARS-CoV-2 virus by inhibiting two key proteases for virus infection and replication. To infect a cell, the SARS-CoV-2 virus must enter a host cell and bind to its membrane receptor ACE-2. The main host protease involved in the activation of protein -S on primary target cells and initial viral entry is the transmembrane serine protease 2 (TMPRSS2). Once in the cell, a fragment of SARS-CoV-2 is cleaved by the 3-chymotrypsin-like cysteine protease (3CL), which controls the replication of the coronavirus, essential for its life cycle. Our hypothesis is that certain PLs could attenuate the effects of the virus by acting on two levels, e.g.: 1) preventing TMPRSS2 from activating the protein -S, and 2) inhibiting the 3CL necessary for the replication and maturation of coronavirus. To do this, we propose 3 objectives: 1- Use a multidisciplinary approach, theoretical (molecular modeling and molecular docking) and experimental (DLS, SPR, particle tracking), to better understand the physicochemical interactions between phenolic ligands and TMPRSS2 and 3CL; 2- In vitro evaluation of protease inhibition by PLs by measuring the cleavage of peptide sequences by TMPRSS2 and 3CL in the presence, or absence, of increasing concentrations of PLs; 3-To assess the effects of PLs on the internalization of viruses mediated by the interaction between the protein -S viral and ACE-2, facilitated by the TMPRSS2, as well as the interactions on cellular models in culture (pulmonary, vascular endothelial cells of the blood-brain-barrier). In addition, as the evidence accumulates on the invasion of SARS-CoV-2 in the nervous system and thus it effects on the brain, we propose to study the effects of PLs on the dorsal root ganglia cell line, on neuronal and microglial cells involved in neuroinflammation because once in the brain, SARS-CoV-2, like SARS-CoV, can induce neuroinflammation. The results of this study will demonstrate the protective potential of PLs against SARS-CoV-2, hence, open up multiple perspectives in the development of treatments for SARS-CoV-2 and in the neuroinvasive mechanisms.
在这项研究中,我们建议证明多酚(Pls)可以通过抑制SARS-CoV-2病毒感染和复制的两个关键蛋白酶来抑制SARS-CoV-2病毒的有害影响。要感染细胞,SARS-CoV-2病毒必须进入宿主细胞,并与其膜受体ACE-2结合。参与S蛋白激活和病毒初始进入的主要宿主酶是跨膜丝氨酸蛋白酶2(TMPRSS2)。一旦进入细胞,SARS-CoV-2的一段片段就会被3-胰凝乳酶样半胱氨酸蛋白酶(3CL)切割,该酶控制冠状病毒的复制,对其生命周期至关重要。我们的假设是,某些PLS可以通过两个水平作用来减弱病毒的作用,例如:1)阻止TMPRSS2激活蛋白-S,2)抑制冠状病毒复制和成熟所需的3CL。为此,我们提出了3个目标:1-使用多学科的方法,理论(分子建模和分子对接)和实验(DLS,SPR,颗粒跟踪),以更好地了解酚类配体与TMPRSS2和3CL之间的物理化学相互作用;2-通过测量在存在或不存在pls浓度增加的情况下,TMPRSS2和3CL对多肽序列的切割来评价pls对蛋白酶的抑制作用;3-通过TMPRSS2促进的蛋白-S病毒与血管紧张素转换酶-2之间的相互作用,以及在培养的细胞模型(肺、血脑屏障的血管内皮细胞)上的相互作用,评估PLS对病毒内化的影响。此外,随着SARS-CoV-2入侵神经系统从而影响大脑的证据的积累,我们建议研究pls对背根节细胞系、参与神经炎症的神经元和小胶质细胞的影响,因为一旦进入大脑,SARS-CoV-2和SARS-CoV一样,可以诱导神经炎症。本研究的结果将证明PLS对SARS-CoV-2的保护作用,从而为SARS-CoV-2的治疗方法和神经侵袭机制的发展开辟了多个视角。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RAMASSAMY, Charles其他文献
RAMASSAMY, Charles的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RAMASSAMY, Charles', 18)}}的其他基金
Elaboration of a Bio-Plex platform for the characterization of Exosomes
构建用于外泌体表征的 Bio-Plex 平台
- 批准号:
570686-2021 - 财政年份:2021
- 资助金额:
$ 3.64万 - 项目类别:
Alliance Grants
Chemical synthesis, isolation, purification and in vivo properties of anthocycanins - FRQNT-Team supplements grant
花青素的化学合成、分离、纯化和体内特性 - FRQNT-团队补充补助金
- 批准号:
560899-2020 - 财政年份:2020
- 资助金额:
$ 3.64万 - 项目类别:
Alliance Grants
Redox stress and neuronal functions
氧化还原应激和神经元功能
- 批准号:
227168-2013 - 财政年份:2017
- 资助金额:
$ 3.64万 - 项目类别:
Discovery Grants Program - Individual
Redox stress and neuronal functions
氧化还原应激和神经元功能
- 批准号:
227168-2013 - 财政年份:2016
- 资助金额:
$ 3.64万 - 项目类别:
Discovery Grants Program - Individual
相似国自然基金
TMPRSS2基因敲除雪貂模型的构建与分析
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
跨膜丝氨酸蛋白酶TMPRSS2基因表达缺失在促进肺腺癌进展和转移中的分子机制研究
- 批准号:
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
抑制NO信号通路在TMPRSS2:ERG阳性前列腺癌生长中作用的研究
- 批准号:LH19H050001
- 批准年份:2018
- 资助金额:0.0 万元
- 项目类别:省市级项目
表达siat7e基因和tmprss2基因MDCK细胞系的建立
- 批准号:31101817
- 批准年份:2011
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
発育鶏卵漿尿膜上に確認した鶏TMPRSS2のインフルエンザウイルス活性化能の解析
鸡胚绒毛尿囊膜上确认的鸡 TMPRSS2 流感病毒激活能力分析
- 批准号:
23K14104 - 财政年份:2023
- 资助金额:
$ 3.64万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
TMPRSS2 as a potential target for treatments of COVID-19 and respiratory infectious viruses in lung
TMPRSS2 作为治疗 COVID-19 和肺部呼吸道感染病毒的潜在靶点
- 批准号:
10454033 - 财政年份:2022
- 资助金额:
$ 3.64万 - 项目类别:
Cooperativity of TMPRSS2-ERG fusion with p53 inactivation in prostate cancer pathogenesis
TMPRSS2-ERG 融合与 p53 失活在前列腺癌发病机制中的协同作用
- 批准号:
10557878 - 财政年份:2022
- 资助金额:
$ 3.64万 - 项目类别:
Blocking TMPRSS2 expression for prevention of SARS-CoV-2 infection
阻断 TMPRSS2 表达以预防 SARS-CoV-2 感染
- 批准号:
10303752 - 财政年份:2021
- 资助金额:
$ 3.64万 - 项目类别:
Covid-19: Fast-tracking treatment by exploiting the steroid hormone receptor/TMPRSS2 axis
Covid-19:利用类固醇激素受体/TMPRSS2 轴进行快速治疗
- 批准号:
10814125 - 财政年份:2021
- 资助金额:
$ 3.64万 - 项目类别:
Role of TMPRSS2 in SARS-CoV-2 induced expression of pro-inflammatory cytokines
TMPRSS2 在 SARS-CoV-2 诱导促炎细胞因子表达中的作用
- 批准号:
458682571 - 财政年份:2021
- 资助金额:
$ 3.64万 - 项目类别:
Research Grants
Covid-19: Fast-tracking treatment by exploiting the steroid hormone receptor/TMPRSS2 axis
Covid-19:利用类固醇激素受体/TMPRSS2 轴进行快速治疗
- 批准号:
10153099 - 财政年份:2021
- 资助金额:
$ 3.64万 - 项目类别:
TMPRSS2 as a potential target for treatments of COVID-19 and respiratory infectious viruses in lung
TMPRSS2 作为治疗 COVID-19 和肺部呼吸道感染病毒的潜在靶点
- 批准号:
10280827 - 财政年份:2021
- 资助金额:
$ 3.64万 - 项目类别:
Modulating COVID-19 disease by targeting virus and virus-induced responses through pharmaceutical and mechanical ventilation strategies: SARS-CoV-2 S-protein, ACE2 and TMPRSS2
通过药物和机械通气策略针对病毒和病毒诱导的反应来调节 COVID-19 疾病:SARS-CoV-2 S 蛋白、ACE2 和 TMPRSS2
- 批准号:
nhmrc : 2003683 - 财政年份:2021
- 资助金额:
$ 3.64万 - 项目类别:
Ideas Grants
Covid-19: Fast-tracking treatment by exploiting the steroid hormone receptor/TMPRSS2 axis
Covid-19:利用类固醇激素受体/TMPRSS2 轴进行快速治疗
- 批准号:
10341159 - 财政年份:2021
- 资助金额:
$ 3.64万 - 项目类别: